Drug Resistant Malaria Due to Plasmodium Falciparum Completed Phase 3 Trials for Amoxicillin (DB01060)

IndicationStatusPhase
DBCOND0077119 (Drug Resistant Malaria Due to Plasmodium Falciparum)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02974348Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara AfricaTreatment